Page last updated: 2024-11-05

tripelennamine and Kidney Failure, Chronic

tripelennamine has been researched along with Kidney Failure, Chronic in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SUSSMAN, RM1
WALD, N1

Other Studies

1 other study available for tripelennamine and Kidney Failure, Chronic

ArticleYear
Tripelennamine dysuria in chronic nephritic uremia.
    The New England journal of medicine, 1952, May-08, Volume: 246, Issue:19

    Topics: Dysuria; Kidney Failure, Chronic; Tripelennamine; Uremia

1952